Solid-phase synthesis and pathological evaluation of pyroglutamate amyloid-β3-42 peptide.
Ontology highlight
ABSTRACT: Pyroglutamate amyloid-β3-42 (AβpE3-42) is an N-terminally truncated and pyroglutamate-modified Aβ peptide retaining highly hydrophobic, amyloidogenic, and neurotoxic properties. In Alzheimer's disease (AD) patients, AβpE3-42 peptides accumulate into oligomers and induce cellular toxicity and synaptic dysfunction. AβpE3-42 aggregates further seed the formation of amyloid plaques, which are the pathological hallmarks of AD. Given that AβpE3-42 peptides play critical roles in the development of neurodegeneration, a reliable and reproducible synthetic access to these peptides may support pathological and medicinal studies of AD. Here, we synthesized AβpE3-42 peptides through the microwave-assisted solid-phase peptide synthesis (
SUBMITTER: Cho I
PROVIDER: S-EPMC9831997 | biostudies-literature | 2023 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA